Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir versus tenofovir after curative resection for HBV-related hepatocellular carcinoma
ChiCTR1800014629Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hepatocellular carcinoma (HCC) and Chronic Hepatitis B (CHB) comparing Entecavir with Tenofovir (2 arms). Primary endpoints: HBsAg, HBsAb and 8 more. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
entecavirtenofovir disoproxil fumarate
03
Conditions
hepatocellular carcinoma (HCC)Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR1800014629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014629.